$GENB 4 SEC Filings

Filed On	Filing
03 Sep 2026	Form 4: Arnold Frances, Director Sold 1,000 shares ($16K)
06 Mar 2026	Form 4: Nally Michael, Director Bought 20,000 shares ($240K)
02 Mar 2026	Form 4: Vessey Rupert, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Grous Beth, Chief People Officer Granted 114,020 Stock Option (Right to Buy) · Bought 300 shares ($4.8K)
02 Mar 2026	Form 4: Arnold Frances, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Lee Laurie Anne, Chief Medical Officer Granted 42,230 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Martin Sean, Chief Legal Officer & GC Granted 190,034 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Simonian Nancy A, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Silvers Jason, President & CFO Granted 570,101 Stock Option (Right to Buy) · Bought 2,000 shares ($32K)
02 Mar 2026	Form 4: Afeyan Noubar, Director and 7 others Granted 29,561 Stock Option (Right to Buy) · Received 32,969,159 shares by conversion · Bought 4,687,500 shares ($75M)
02 Mar 2026	Form 4: Grigoryan Gevorg, Chief Technology Officer Granted 491,976 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Nally Michael, Director Granted 1,689,190 Stock Option (Right to Buy) · Received 658,327 shares by conversion
02 Mar 2026	Form 4: Bancel Stephane, Director Granted 29,561 Stock Option (Right to Buy) · Received 724,160 shares by conversion
02 Mar 2026	Form 4: Mendillo Jane L, Director Granted 29,561 Stock Option (Right to Buy) · Bought 1,500 shares ($24K)
02 Mar 2026	Form 4: Fanucci Marsha, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Parker Paul Gray, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Afeyan Noubar, Director and 6 others Granted 29,561 Stock Option (Right to Buy) · Received 32,969,159 shares by conversion · Bought 4,687,500 shares ($75M)

Comments